Clinical Trial Update: Percutaneous Bilateral Versus Unilateral Metal Stent for Hilar Cholangiocarcinoma [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update comparing percutaneous bilateral versus unilateral metal stent for hilar cholangiocarcinoma across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hilar Cholangiocarcinoma

Drugs mentioned

• metal stent (metal stent)

Snippet

Sponsor: Air Force Military Medical University, China | Conditions: Hilar Cholangiocarcinoma | Phase 2, Phase 3 | Status: UNKNOWN